不成熟的血小板断裂和急性冠状动脉综合征;系统性审查和元分析
Elmira Jafari Afshar1,2, Vahid Shahnavaz1,2, Hamed Talakoob1
1Cardiovascular Research Center, Alborz University of Medical Sciences, Alborz, Iran.
Archives of academic emergency medicine
|July 4, 2024
概括
在急性冠状动脉综合征 (ACS) 患者中,不成熟血小板分数 (IPF) 升高,可以帮助区分ACS亚型. 这种生物标志物对早期诊断和区分心肌梗塞和不稳定性胸痛等疾病有希望.
科学领域:
- 心脏病学 心脏病学
- 血液学 血液学 血液学
- 生物标志物发现发现
背景情况:
- 不成熟的血小板分数 (IPF) 表示循环的网状血小板.
- 在急性冠状动脉综合征 (ACS) 中,IPF具有潜在的预后和诊断价值.
- 区分ACS亚型对于有效的患者管理至关重要.
研究的目的:
- 系统地审查和总结IPF水平在ACS患者的诊断效用.
- 评估IPF区分各种ACS亚型的能力.
主要方法:
- 在MEDLINE,Scopus和Google Scholar的系统文献搜索到2024年3月.
- 使用随机效应模型的元分析 (MD的反变异,OR的Mantle-Haenszel).
- 使用Joanna Briggs Institute (JBI) 评估工具对包括的研究进行质量评估.
主要成果:
- 包括15项研究,涉及2030名ACS患者.
- 与健康对照组相比,ACS患者的IPF水平显著更高 (MD:2.85) 和稳定性胸痛 (MD:0.58).
- 在心肌梗塞 (MI) 与不稳定性胸痛 (UA) (MD:1.81),STEMI与NSTEMI (MD:0.74),以及NSTEMI与UA (MD:1.07) 中观察到更高的IPF水平.
结论:
- 在ACS患者中,IPF水平增加,特别是在急性ST升高MI (STEMI) 期间.
- IPF作为早期ACS诊断的潜在生物标志物.
- IPF有助于区分ACS亚型,包括MI,STEMI,NSTEMI和UA.
相关概念视频
Formation of the Platelet Plug
5.7K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
5.7K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
514
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
514
Structure and Function of Platelets
1.1K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
1.1K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
672
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
672
Clot Retraction and Fibrinolysis
5.4K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
5.4K
Introduction to Hemostasis
7.1K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
7.1K


